Skip to content

Elecsys total PSA 08791716160Recalls & reported problems

Roche Diagnostics GmbH · Class 3

All models of Elecsys total PSA (5)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07613336166000), received between Dec 28, 2022 and Mar 14, 2024 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Low Test Results” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Low Test Results2
  • Non Reproducible Results2

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 14, 2024Low Test Results; Non Reproducible Results; Low Test Results; Non Reproducible Results

    THERE WAS AN ALLEGATION OF QUESTIONABLE TOTAL PSA ELECSYS RESULTS FROM THE COBAS 8000 - COBAS E 602 MODULE. PATIENT 1 INITIAL RESULT WAS <0.010 NG/ML AND REPEAT THE RESULT WAS APPROXIMATELY 9 NG/ML. PATIENT 2 INITIAL RESULT WAS <0.010 NG/ML AND THE REPEAT RESULT WAS APPROXIMATELY 4 NG/ML. THE QUESTIONABLE RESULTS WERE NOT REPORTED OUTSIDE OF THE LABORATORY. THE REPEAT RESULT WAS BELIEVED CORRECT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18904165 ↗
  • MalfunctionDec 28, 2022Low Test Results; Non Reproducible Results; Low Test Results; Non Reproducible Results

    THERE WAS AN ALLEGATION OF QUESTIONABLE ELECSYS TOTAL PSA IMMUNOASSAY RESULTS FOR 1 PATIENT SAMPLE ON A COBAS 6000 E601 MODULE. THE INITIAL TOTAL PSA RESULT WAS 0.032 NG/ML. THE INITIAL RESULT WAS REPORTED OUTSIDE OF THE LABORATORY. THE PHYSICIAN QUESTIONED THE RESULT AND THE SAMPLE WAS REPEATED. THE SAMPLE WAS REPEATED TWICE AND THE RESULTS WERE 3.01 NG/ML AND 2.97 NG/ML. THE RESULT OF 3.01 NG/ML WAS DEEMED CORRECT. THE REAGENT LOT IS 64096301 AND THE EXPIRATION DATE IS 31-JAN-2024.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16061672 ↗

Other Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer devices

All Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page